Deiter Ziegler

Title: Deiter Ziegler: Innovator in Diuretic Treatment

Introduction

Deiter Ziegler is a notable inventor based in Ronnenberg, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in diuretic treatments. His innovative approach has led to the development of a unique method that addresses the needs of mammals requiring diuretic therapy.

Latest Patents

Ziegler holds a patent for a method of diuretic treatment utilizing 3,7-diazabicyclo[3,3,1]nonane compounds. This patent outlines a method for treating mammals in need of diuretic treatment by administering an effective diuretic amount of a diuretically active 3,7,9,9-tetrasubstituted 3,7-diazabicyclo[3,3,1]nonane compound. The patent also includes diuretic pharmaceutical compositions containing these compounds, as well as previously unknown diuretically active compounds that feature an optionally substituted phenylalkyl group in the 3-position.

Career Highlights

Deiter Ziegler is associated with Kali-Chemie Pharma GmbH, where he has been instrumental in advancing pharmaceutical research and development. His work has focused on creating effective treatments that improve patient outcomes in diuretic therapy.

Collaborations

Ziegler has collaborated with notable colleagues, including Kurt Burow and Gerd Buschmann. These partnerships have fostered a collaborative environment that enhances innovation and research in the pharmaceutical sector.

Conclusion

Deiter Ziegler's contributions to diuretic treatment through his innovative patent demonstrate his commitment to improving healthcare solutions. His work continues to influence the pharmaceutical industry and offers promising advancements in medical treatments.